Evidence map›Paper›PMID 35053203›Full record

ArticleBiomolecules2021

Point Mutations at a Key Site Alter the Cytochrome P450 OleP Structural Dynamics.

Linda Celeste Montemiglio, Elena Gugole, Ida Freda, Cécile Exertier, Lucia D'Auria, Cheng Giuseppe Chen, Alessandro Nicola Nardi, Gabriele Cerutti, Giacomo Parisi, Marco D'Abramo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Tumor metabolic crosstalk and immunotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  6. Differential Effects of Clotrimazole on X-Ray Crystal Structures of Human Cytochromes P450 3A5 and 3A4.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Linda Celeste MontemiglioInstitute of Molecular Biology and Pathology, CNR c/o Department of Biochemical Sciences "A. Rossi Fanelli", University of Rome, Sapienza, P.le A. Moro 5, 00185 Rome, Italy.ORCID 0000-0002-4253-7493
Elena GugoleDepartment of Biochemical Sciences "A. Rossi Fanelli", University of Rome, Sapienza, P.le A. Moro 5, 00185 Rome, Italy.ORCID 0000-0001-8622-3886
Ida FredaDepartment of Biochemical Sciences "A. Rossi Fanelli", University of Rome, Sapienza, P.le A. Moro 5, 00185 Rome, Italy.ORCID 0000-0002-0756-9537
Cécile ExertierInstitute of Molecular Biology and Pathology, CNR c/o Department of Biochemical Sciences "A. Rossi Fanelli", University of Rome, Sapienza, P.le A. Moro 5, 00185 Rome, Italy.ORCID 0000-0001-7457-6895
Lucia D'AuriaDepartment of Biochemical Sciences "A. Rossi Fanelli", University of Rome, Sapienza, P.le A. Moro 5, 00185 Rome, Italy.
Cheng Giuseppe ChenDepartment of Chemistry, University of Rome, Sapienza, P.le A. Moro 5, 00185 Rome, Italy.ORCID 0000-0003-3553-4718
Alessandro Nicola NardiDepartment of Chemistry, University of Rome, Sapienza, P.le A. Moro 5, 00185 Rome, Italy.
Gabriele CeruttiDepartment of Biochemical Sciences "A. Rossi Fanelli", University of Rome, Sapienza, P.le A. Moro 5, 00185 Rome, Italy.ORCID 0000-0002-9081-7561
Giacomo ParisiCenter for Life Nano & Neuro-Science, Fondazione Istituto Italiano di Tecnologia, IIT, 00185 Rome, Italy.ORCID 0000-0002-3064-0928
Marco D'AbramoDepartment of Chemistry, University of Rome, Sapienza, P.le A. Moro 5, 00185 Rome, Italy.ORCID 0000-0001-6020-8581
Carmelinda SavinoInstitute of Molecular Biology and Pathology, CNR c/o Department of Biochemical Sciences "A. Rossi Fanelli", University of Rome, Sapienza, P.le A. Moro 5, 00185 Rome, Italy.
Beatrice ValloneDepartment of Biochemical Sciences "A. Rossi Fanelli", University of Rome, Sapienza, P.le A. Moro 5, 00185 Rome, Italy.
Sapienza University of Rome · ITInstitute of Molecular Biology and Pathology · ITItalian Institute of Technology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Substrate binding to the cytochrome P450 OleP is coupled to a large open-to-closed transition that remodels the active site, minimizing its exposure to the external solvent. When the aglycone substrate binds, a small empty cavity is formed between the I and G helices, the BC loop, and the substrate itself, where solvent molecules accumulate mediating substrate-enzyme interactions. Herein, we analyzed the role of this cavity in substrate binding to OleP by producing three mutants (E89Y, G92W, and S240Y) to decrease its volume. The crystal structures of the OleP mutants in the closed state bound to the aglycone 6DEB showed that G92W and S240Y occupied the cavity, providing additional contact points with the substrate. Conversely, mutation E89Y induces a flipped-out conformation of this amino acid side chain, that points towards the bulk, increasing the empty volume. Equilibrium titrations and molecular dynamic simulations indicate that the presence of a bulky residue within the cavity impacts the binding properties of the enzyme, perturbing the conformational space explored by the complexes. Our data highlight the relevance of this region in OleP substrate binding and suggest that it represents a key substrate-protein contact site to consider in the perspective of redirecting its activity towards alternative compounds.

Indexed as

Cytochrome P-450 Enzyme SystemPoint MutationBinding SitesCatalytic DomainCrystallography, X-RayProtein Structure, SecondarySubstrate SpecificityCytochrome P-450 Enzyme Systemconformational spacecytochrome P450MD simulationOlePP450 structural dynamicssite directed mutagenesisX-ray crystallography

Identifiers

PMID35053203
PMCPMC8774231
OpenAlexW4206720632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.